Evelo Biosciences Reports Fourth Quarter and Full Year 2018 Financial Results and Business Highlights
— First Patient Dosed in University of Chicago Phase 2a Trial of EDP1503 in Metastatic Melanoma —— Preclinical Studies Have […]
— First Patient Dosed in University of Chicago Phase 2a Trial of EDP1503 in Metastatic Melanoma —— Preclinical Studies Have […]
Conference Call and Webcast Scheduled for Tuesday, February 19, 2019 at 8:00 a.m. ET MALVERN, Pa., Feb. 14, 2019 (GLOBE […]
WATERTOWN, Mass., Feb. 14, 2019 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and […]
HOUSTON, Feb. 14, 2019 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, announced that the company has […]
ALACHUA, Fla., Feb. 14, 2019 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative […]
Transition of small molecule expertise to Arvelle completes transformation of Axovant into a company focused exclusively on gene therapies Axovant […]
New line doubles capacity of Midland facility in IPG’s fastest growing segment MONTREAL and SARASOTA, Fla., Feb. 14, 2019 (GLOBE […]
VANCOUVER, British Columbia, Feb. 14, 2019 (GLOBE NEWSWIRE) — Asanko Gold Inc. (“Asanko” or the “Company”) (TSX, NYSE American: AKG) […]
TORONTO, Feb. 14, 2019 (GLOBE NEWSWIRE) — Galantas Gold Corporation (the ‘Company’) (TSXV:GAL) (AIM:GAL), reports that it has awarded 3,200,000 […]
Phase 2 Typhoon EM Survey Commences at Yepleu and Grata MONTREAL, Feb. 14, 2019 (GLOBE NEWSWIRE) — Sama Resources Inc. […]